542 related articles for article (PubMed ID: 25747324)
1. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
[TBL] [Abstract][Full Text] [Related]
2. Statins and renin-angiotensin system inhibitor combination treatment to prevent cardiovascular disease.
Lee HY; Sakuma I; Ihm SH; Goh CW; Koh KK
Circ J; 2014; 78(2):281-7. PubMed ID: 24401609
[TBL] [Abstract][Full Text] [Related]
3. Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.
Koh KK; Sakuma I; Shimada K; Hayashi T; Quon MJ
Korean Circ J; 2017 Jul; 47(4):432-439. PubMed ID: 28765731
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia.
Borghi C; Urso R; Cicero AF
Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):115-120. PubMed ID: 27745933
[TBL] [Abstract][Full Text] [Related]
6. Does reversal of oxidative stress and inflammation provide vascular protection?
Koh KK; Oh PC; Quon MJ
Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress: the EPAS trial.
Morawietz H; Erbs S; Holtz J; Schubert A; Krekler M; Goettsch W; Kuss O; Adams V; Lenk K; Mohr FW; Schuler G; Hambrecht R
Circulation; 2006 Jul; 114(1 Suppl):I296-301. PubMed ID: 16820589
[TBL] [Abstract][Full Text] [Related]
8. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
9. Should angiotensin II receptor blockers and statins be combined?
Nickenig G
Circulation; 2004 Aug; 110(8):1013-20. PubMed ID: 15326080
[No Abstract] [Full Text] [Related]
10. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Yamagishi S; Takeuchi M
Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction.
Koh KK; Han SH; Oh PC; Shin EK; Quon MJ
Atherosclerosis; 2010 Apr; 209(2):307-13. PubMed ID: 19800624
[TBL] [Abstract][Full Text] [Related]
12. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
13. Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.
Drapala A; Sikora M; Ufnal M
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):250-8. PubMed ID: 25037529
[TBL] [Abstract][Full Text] [Related]
14. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
15. Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.
Sirenko Y; Radchenko G;
High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):85-93. PubMed ID: 28150140
[TBL] [Abstract][Full Text] [Related]
16. Best Treatment Strategies With Statins to Maximize the Cardiometabolic Benefits.
Cho KI; Sakuma I; Sohn IS; Hayashi T; Shimada K; Koh KK
Circ J; 2018 Mar; 82(4):937-943. PubMed ID: 29503409
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
Lu H; Balakrishnan A; Howatt DA; Wu C; Charnigo R; Liau G; Cassis LA; Daugherty A
Br J Pharmacol; 2012 Mar; 165(6):2000-2008. PubMed ID: 22014125
[TBL] [Abstract][Full Text] [Related]
18. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.
Jandeleit-Dahm KA; Tikellis C; Reid CM; Johnston CI; Cooper ME
J Hypertens; 2005 Mar; 23(3):463-73. PubMed ID: 15716683
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardiovascular events in patients with angiographically documented coronary narrowing with combined renin-angiotensin system inhibitor plus statin versus renin-angiotensin system inhibitor alone versus statin alone (from the Japanese Coronary Artery Disease Study).
Fujita M; Yamazaki T; Hayashi D; Kohro T; Okada Y; Nagai R;
Am J Cardiol; 2007 Dec; 100(12):1750-3. PubMed ID: 18082520
[TBL] [Abstract][Full Text] [Related]
20. On target to dual block RAS?
Papadopoulos DP; Papademetriou V; Makris TK
Angiology; 2009 Dec-2010 Jan; 60(6):739-49. PubMed ID: 19144653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
